Skip to main content
OpenTrials

Clinical trial condition

Haemophilia A

Explore clinical trials studying Haemophilia A. Study availability and eligibility vary by location and protocol.

76 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Haemophilia A trial results

Completed

A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B

NCT03055611

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • Swedish Orphan Biovitrum Reserach site Berlin, Germany
  • Swedish Orphan Biovitrum Reserach Site Blaubeuren Abbey, Germany
  • Swedish Orphan Biovitrum Research Site Bonn, Germany
  • Swedish Orphan Biovitrum Research Site Delmenhorst, Germany
View all 22 locations
View Trial Details
Completed

An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment

NCT04165135

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • AOU Cons. Policlinico Bari; Centro Emofilia e Trombosi - UO Medicina Trasfusionale Bari, Apulia, Italy
  • Az. Osp. Pugliese Ciaccio; S. C. Emofilia, Emostasi e Trombosi Catanzaro, Calabria, Italy
  • AOU Federico II; Medicina Clinica Chirurgia Centro Emocoaugulopatie e Emofilia Naples, Campania, Italy
  • PO Cesena - Osp M. Bufalini; Patologia Clinica - S.S.A. Serv. Medicina Trasf.- Centro Emofilia Cesena, Emilia-Romagna, Italy
View all 17 locations
View Trial Details
Completed

Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B

NCT03276130

Conditions
Anxiety Disorders, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +16 more
Locations
  • Swedish Orphan Biovitrum Research Site Copenhagen, Denmark
  • Swedish Orphan Biovitrum Research Site Helsinki, Finland
  • Swedish Orphan Biovitrum Research Site Gothenburg, Sweden
  • Swedish Orphan Biovitrum Research Site Malmö, Sweden
View Trial Details
Completed

Turoctocog Alfa in Haemophilic Italian Patients: Protection and Engagement in Recreational Activities

NCT04584892

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Novo Nordisk Investigational Site Milan, MI, Italy
  • Novo Nordisk Investigational Site Bologna, Italy
  • Novo Nordisk Investigational Site Castelfranco Veneto, Italy
  • Novo Nordisk Investigational Site Catania, Italy
View Trial Details
Completed

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A

NCT03528551

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Long Beach, California, United States
  • Novo Nordisk Investigational Site Iowa City, Iowa, United States
  • Novo Nordisk Investigational Site New Orleans, Louisiana, United States
View all 67 locations
View Trial Details
Completed

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

NCT03741881

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +12 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Sacramento, California, United States
  • Novo Nordisk Investigational Site Aurora, Colorado, United States
  • Novo Nordisk Investigational Site Washington D.C., District of Columbia, United States
View all 143 locations
View Trial Details
Completed

A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors

NCT03196297

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Indianapolis, Indiana, United States
  • Novo Nordisk Investigational Site Oklahoma City, Oklahoma, United States
  • Novo Nordisk Investigational Site Nashville, Tennessee, United States
View all 31 locations
View Trial Details

Related conditions